Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
ACS Appl Mater Interfaces ; 11(3): 2870-2879, 2019 Jan 23.
Article in English | MEDLINE | ID: mdl-30589525

ABSTRACT

Injectable and phase-transitioning carriers from natural polysaccharides have great potential for the minimally invasive delivery of therapeutic proteins in the field of bone tissue engineering. In this study, a novel and highly viscous drug carrier was synthesized by a sequential process of deoxyribose polycondensation and esterification. The effect of synthesis parameters on the molecular weight, viscosity, and adhesion of the material was studied and correlated to temperature and time of polycondensation ( Tp and tp), time and temperature of esterification ( Te and te), and the molar ratio of the monomer ( R). The formulations were evaluated for molecular weight and distribution properties using GPC, chemical structures by FTIR and NMR spectra, and rheological properties using a rheometer. Formulations illustrated a wide range of viscosities (0.736 to 2225 Pa s), adhesion (0.896 to 58.45 N), and molecular weights (637 to 4216 Da), where viscosity was significantly reduced in the presence of low amounts of solvents (10-20%). The sustained release of BSA was observed over 42 days in vitro. The biocompatibility of poly(deoxyribose) isobutyrate (PDIB) as well as its potential as a bone morphogenetic protein delivery system was assessed in vivo using a rat ectopic bone model, where bone nodules were observed at 2 weeks. In summary, PDIB is a promising molecule with multiple applications for protein delivery, including for bone tissue engineering.


Subject(s)
Biocompatible Materials/pharmacology , Bone Morphogenetic Protein 2/pharmacology , Drug Delivery Systems , Tissue Engineering , Biocompatible Materials/chemistry , Bone Morphogenetic Protein 2/chemistry , Deoxyribose/chemistry , Drug Carriers/chemistry , Drug Carriers/pharmacology , Humans , Isobutyrates/chemistry , Rheology , Viscosity/drug effects
2.
Biomacromolecules ; 18(6): 1736-1746, 2017 Jun 12.
Article in English | MEDLINE | ID: mdl-28535038

ABSTRACT

Biodegradable polymers are appealing material for the manufacturing of surgical implants as such implants break down in vivo, negating the need for a subsequent operation for removal. Many biocompatible polymers produce acidic breakdown products that can lead to localized inflammation and osteolysis. This study assesses the feasibility of fabricating implants out of poly(propylene carbonate) (PPC)-starch that degrades into CO2 and water. The basic compression modulus of PPC-starch (1:1 w/w) is 34 MPa; however, the addition of glycerol (1% w/w) and water as plasticizers doubles this value and enhances the surface wettability. The bioactivity and stiffness of PPC-starch blends is increased by the addition of bioglass microparticles (10% w/w) as shown by in vitro osteoblast differentiation assay and mechanical testing. MicroCT analysis confirms that the bioglass microparticles are evenly distributed throughout biomaterial. PPC-starch-bioglass was tested in vivo in two animal models. A murine subcutaneous pellet degradation assay demonstrates that the PPC-starch-bioglass blend's volume fraction loss is 46% after 6 months postsurgery, while it is 27% for poly(lactic acid). In a rat knee implantation model, PPC-starch-bioglass screws inserted into the distal femur show osseointegration with no localized adverse effects after 3 and 12 weeks. These data support the further development of PPC-starch-bioglass as a medical biomaterial.


Subject(s)
Absorbable Implants , Biocompatible Materials/chemical synthesis , Bone-Implant Interface/physiology , Ceramics/pharmacology , Polypropylenes/chemical synthesis , Starch/chemistry , Animals , Biocompatible Materials/metabolism , Biocompatible Materials/pharmacology , Bone-Implant Interface/anatomy & histology , Bone-Implant Interface/diagnostic imaging , Carbon Dioxide/metabolism , Cell Differentiation/drug effects , Cell Line, Tumor , Ceramics/chemistry , Female , Femur/surgery , Glycerol/chemistry , Glycerol/metabolism , Humans , Hydrolysis , Male , Mice , Mice, Inbred BALB C , Osteoblasts/cytology , Osteoblasts/drug effects , Polypropylenes/metabolism , Polypropylenes/pharmacology , Rats , Starch/metabolism , Water/metabolism , Wettability
SELECTION OF CITATIONS
SEARCH DETAIL
...